Reuters exclusively reported that Danaher Corp (DHR.N) is in the lead to acquire Abcam Plc, a provider of supplies to life science researchers with a market value of $5.4 billion, as it expands its biomedical offerings.
Abcam shares rose as much as 9% in afternoon trading in New York on Friday to $24.52. Danaher shares were up 1.3% at $256.76.
Topics of Interest: Deals
Type: Reuters Best
Sectors: Business & Finance
Countries: EnglandUnited States
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Important Regional Story